The effects of repeated doses of clomipramine and alprazolam on physiological, psychomotor and cognitive functions in normal subjects
The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Abstract
The effects of a 10 day administration of clomipramine (25-50 mg t.i.d.), alprazolam (0.25-0.75 mg t.i.d.) and placebo were assessed in normal volunteers in a double-blind cross-over study. A battery of physiological, psychomotor and cognitive tests was administered both before and 3 h after drug on days 1, 5 and 10. The effects of alprazolam on EEG and evoked potentials were characteristic of benzodiazepines; clomipramine had little effect. In contrast, reaction speed was markedly slowed by clomipramine but little affected by alprazolam. Neither drug produced any accumulation of effect on a verbal recall task but neither did tolerance develop to the acute impairments produced by active treatments. Alprazolam produced an increase in levels of forgetting, especially on day 5. Subjective ratings for mood and bodily symptoms were adversely affected by clomipramine but little altered by alprazolam. It is suggested that some of the differences between drug treatments may be due to differences in the speed of onset of tolerance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Also, no tolerance for memory-impairing effects of alprazolam was found during a 10-day acute treatment [41].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [41]
In the citing paper
“Moreover, tolerance to benzodiazepine-induced decreased reaction speed was shown after 10 days of alprazolam treatment [41].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [41]
Citations
Cites
Manual for the Wechsler Adult Intelligence Scale.
Wechsler, D. (1955) · Psychological Corp. eBooks · Cited by 4,941
Battig, W. F., & Montague, W. E. (1969) · Journal of Experimental Psychology · doi:10.1037/h0027577 · Cited by 2,570
The use of analogue scales in rating subjective feelings
BOND, A., & LADER, M. (1974) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1974.tb02285.x · Cited by 1,972 · cited 1×
“A principal component analysis of this scale has yielded three factors [Bond and Lader 1974] namely, 'alertness' (Mood Factor 1), 'contentedness' (Mood Factor 2) and 'calmness' (Mood Factor 3).”
Self-citationThe Cholinergic Synapse and the Site of Memory
Deutsch, J. A. (1971) · Science · doi:10.1126/science.174.4011.788 · Cited by 661 · cited 1×
“Learning and memory are thought to involve cholinergic mediation [Deutsch 1971; Drachman 1978] so that antidepressants with anticholinergic effects may produce impairments in people's ability to learn and remember.”
BackgroundBallenger, J. C. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290027004 · Cited by 564 · cited 1×
“…has also been shown to be effective in treating panic disorders [Chouinard et al. 1982; Alexander and Alexander 1986; Ballenger et al. 1988] and, in contrast to antidepressants appears to be well tolerated by patients and to have minimal side effects [Noyes et al.…”
ResultPsychopharmacology: A Generation of Progress
Abrams, A. A. (1978) · Psychosomatic Medicine · doi:10.1097/00006842-197810000-00010 · Cited by 416
Tranquillising memories: A review of the effects of benzodiazepines on human memory
Curran, H. V. (1986) · Biological Psychology · doi:10.1016/0301-0511(86)90081-5 · Cited by 298 · cited 2×
“Benzodiazepines also have clear sedative properties and the degree to which their amnesic effects are by-products of changes in arousal levels is also a question of debate [ Curran 1986; Roth et al. 1984].”
BackgroundResultSelf-citationChouinard, G., Annable, L., Fontaine, R., & Solyom, L. (1982) · Psychopharmacology · doi:10.1007/bf00464571 · Cited by 256 · cited 1×
“The triazolo-benzodiazepine, alprazolam, has also been shown to be effective in treating panic disorders [Chouinard et al. 1982; Alexander and Alexander 1986; Ballenger et al. 1988] and, in contrast to antidepressants appears to be well tolerated by patients and to have minimal side effects [Noyes et al.”
BackgroundPecknold, J. C. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290043006 · Cited by 204 · cited 1×
“On the debit side, discontinuation of alprazolam may present some problems [Pecknold et al. 1988].”
BackgroundMcTavish, D., & Benfield, P. (1990) · Drugs · doi:10.2165/00003495-199039010-00010 · Cited by 161
Research works printed but not linked: 2
- Baddeley AD, Sutherland A, Harris J (1982) How well do laboratory-based psychological tests predict patient's performance outside the laboratory? Aging 19: 141?148
- Modigh K (1989) A treatment programme for panic disorder. In: Kielholz P, Adams C (eds) Panic anxiety states. Deutscher Ärzte-Verlag, Köln
Cited by
Cognitive Effects of Long-Term Benzodiazepine Use: A Meta-Analysis
Barker, M. J., Greenwood, K. M., Jackson, M., & Crowe, S. F. (2004) · CNS Drugs · doi:10.2165/00023210-200418010-00004 · Cited by 552
Zaleplon - a review of a novel sedative hypnotic used in the treatment of insomnia
Heydorn, W. E. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.4.841 · Cited by 195
Vinkers, C. H., & Olivier, B. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/416864 · Cited by 195
“Moreover, tolerance to benzodiazepine-induced decreased reaction speed was shown after 10 days of alprazolam treatment [41].”
BackgroundVerster, J. C., & Volkerts, E. R. (2004) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2004.tb00003.x · Cited by 150
“For example, significantly reduced N1 and P1 amplitudes have been found after alprazolam administration (6,25,242), reflecting the inhibitory activity of alprazolam.”
BackgroundMataix-Cols, D., Alonso, P., Pifarré, J., Menchón, J. M., & Vallejo, J. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00024-0 · Cited by 116
“times (Allen et al., 1991), and impaired verbal”
ResultBenzodiazepine Sensitivity in Panic Disorder: Effects of Chronic Alprazolam Treatment
Cowley, D. S., Roy-Byrne, P. P., Radant, A., Ritchie, J. C., Greenblatt, D. J., Nemeroff, C. B., & Hommer, D. W. (1995) · Neuropsychopharmacology · doi:10.1038/sj.npp.1380249 · Cited by 87
Memory and psychomotor effects of oxcarbazepine in healthy human volunteers
Curran, H. V., & Java, R. I. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf02440853 · Cited by 70
Self-citationCognitive performance in depressed patients after chronic use of antidepressants
Gorenstein, C., de Carvalho, S. C., Artes, R., Moreno, R. A., & Marcourakis, T. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0274-2 · Cited by 71
“A similar interpretation may be made for fluoxetine. studies (e.g. Allen et al. 1991; Meyers et al. 1991; Sakulsripong et al. 1991) have explored antidepressant effects on metamemory, i.e. the knowledge and judgment by the individual of his/her own capacity to acquire, retain and recall information…”
BackgroundAllen, D., Curran, H. V., & LADER, M. H. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf00265947 · Cited by 64
“Digit span. Digit span was measured as described by Allen et al. (1991) .”
MethodSelf-citationCognitive toxicity of pharmacotherapeutic agents used in social anxiety disorder
Hindmarch, I. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02085.x · Cited by 61
Abramovitch, A., Mittelman, A., Tankersley, A. P., Abramowitz, J. S., & Schweiger, A. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.04.025 · Cited by 56
“…neuropsychological performance in healthy controls (Paul et al., 2007) or individuals with OCD (Mataix-Cols et al., 2002), there is anecdotal evidence that Clomipramine, a second-line treatment for OCD, may adversely impact certain cognitive functions (Allen et al., 1991; Serretti et al., 2010).”
Curran, H. V., Bond, A., O'Sullivan, G., Bruce, M., Marks, I., Lelliot, P., Shine, P., & Lader, M. (1994) · Psychological Medicine · doi:10.1017/s0033291700029056 · Cited by 54
Self-citationVermeeren, A., Muntjewerff, N. D., Quint, P. J., O’Hanlon, J. F., Jackson, J. L., & Harrison, E. M. (1995) · Psychopharmacology · doi:10.1007/bf02245243 · Cited by 46
“One study measured memory effects in tests repeated during a 10-day escalating dose series, 0.25-0.50-1.00 mg (Allen et al. 1991).”
BackgroundInfluentialBlin, O., Simon, N., Jouve, E., Habib, M., Gayraud, D., Durand, A., Bruguerolle, B., & Pisano, P. (2001) · Clinical Neuropharmacology · doi:10.1097/00002826-200103000-00002 · Cited by 41
Buffett-Jerrott, S. E., Stewart, S. H., & Teehan, M. D. (1998) · Psychopharmacology · doi:10.1007/s002130050680 · Cited by 42
Szabadi, E., & Tavernor, S. (1999) · CNS Drugs · doi:10.2165/00023210-199911060-00004 · Cited by 42
Avoiding and Managing Anticholinergic Effects of Antidepressants
Riedel, W. J., & van Praag, H. M. (1995) · CNS Drugs · doi:10.2165/00023210-199503040-00002 · Cited by 34
Cuevas, C. D. L., Ramallo‐Fariña, Y., & Sanz, E. J. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.02.013 · Cited by 30
“Whereas there is already considerable evidence that old forms of psychiatric drug treatments such as benzodiazepines, tricyclic antidepressants and typical neuroleptics affect psychomotor functions (Allen et al., 1991; Bartfai et al., 1991; Wylie et al., 1993; AmadoBoccara et al., 1994; Grabe et al., 1999; de Carvalho…”
BackgroundBuffett-Jerrott, S. E., Stewart, S. H., Bird, S. J., & Teehan, M. D. (1998) · Journal of Psychopharmacology · doi:10.1177/026988119801200403 · Cited by 33
Berthelon, C., Bocca, M., Denise, P., & Pottier, A. (2003) · Journal of Psychopharmacology · doi:10.1177/02698811030173015 · Cited by 24
“…proportion of hypnotic drug consumers only use them occasionally and temporarily, and that the cognitive and psychomotor deterioration which follows their use can be especially strong at the start of treatment (Hindmarch and Kern, 1992), tending to decrease after a few days (Allen et al., 1991).”
BackgroundAmnestic and anxiolytic effects of alprazolam in oral surgery patients
Coldwell, S. E., Milgrom, P., Getz, T., & Ramsay, D. S. (1997) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/s0278-2391(97)90280-9 · Cited by 27
Emel, K. U. R. T., Yıldırım, E., & Topçuoğlu, V. (2017) · Nöro Psikiyatri Arşivi · doi:10.5152/npa.2016.14872 · Cited by 23
“It has been reported that shortly after the application of clomipramine, patients experience slowness in reaction time, impairment in verbal learning, and remembering (38, 39).”
BackgroundThe tricyclic antidepressant clomipramine inhibits neuronal autophagic flux
Cavaliere, F., Fornarelli, A., Bertan, F., Russo, R., Marsal-Cots, A., Morrone, L. A., Adornetto, A., Corasaniti, M. T., Bano, D., Bagetta, G., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-40887-x · Cited by 21
Suetsugi, M., Mizuki, Y., Ushijima, I., Yamada, M., & Imaizumi, J. (1998) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(97)00182-6 · Cited by 20
The effects of alprazolam alone and combined with alcohol on central integrative activity
Bond, A. J., Silveira, J. C., & LADER, M. H. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf00314857 · Cited by 20
Self-citationCognitive effects of benzodiazepine use: a review
Barker, M., Jackson, M., Greenwood, K. M., & Crowe, S. F. (2003) · Australian Psychologist · doi:10.1080/00050060310001707217 · Cited by 24
The effects of single doses of lorazepam on event-related potentials and cognitive function
Pooviboonsuk, P., Dalton, J. A., Curran, H. V., & LADER, M. H. (1996) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199605)11:3<241::aid-hup795>3.0.co;2-0 · Cited by 19
Self-citationLucchesi, L. M., Pompéia, S., Manzano, G. M., Kohn, A. F., Galduróz, J. C. F., Bueno, O. F. A., & Tufik, S. B. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00044-7 · Cited by 23
“BZD-induced decreases of N1, P2, and N2 have been considered as a generalised decrease of neuronal activity related to sedation (Allen et al., 1991).”
BackgroundAlprazolam 0.125 mg Twice a Day Improves Aspects of Psychometric Performance in Healthy Volunteers
Bourin, M., Colombel, M.-C., & Guitton, B. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199810000-00003 · Cited by 18
Switch in Treatment From Tricyclic Antidepressants to Moclobemide
Dingemanse, J., Kneer, J., Fotteler, B., Groen, H., Peeters, P. A. M., & Jonkman, J. H. G. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199502000-00007 · Cited by 16
Blanco‐Hinojo, L., Pujol, J., Macià, D., Martínez‐Vilavella, G., Martín‐Santos, R., Pérez, V., & Deus, J. (2021) · Brain Connectivity · doi:10.1089/brain.2020.0844 · Cited by 15
“…in neurophysiological studies, and its effects on electroencephalography (EEG) are characteristic of benzodi-azepines in that they cause a decrease in cortical alpha and an increase in beta activity (Allen et al., 1991; Barbanoj et al., 2007), generally associated with such inhibitory states.”
Chemo brain – A psychotropic drug phenomenon?
Jackson, G. E. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.06.019 · Cited by 20
Lorazepam 0.25 mg twice a day improves aspects of psychometric performance in healthy volunteers
Bourin, M., Colombel, M.-C., & Malinge, M. (1995) · Journal of Psychopharmacology · doi:10.1177/026988119500900308 · Cited by 15
Memory performance in panic disorder patients after chronic use of clomipramine
de Carvalho, S. C., Marcourakis, T., Artes, R., & Gorenstein, C. (2002) · Journal of Psychopharmacology · doi:10.1177/026988110201600305 · Cited by 19
Acute neurophysiological effects of the hypnotic zolpidem in healthy volunteers
Lucchesi, L. M., Braga, N. I. D. O., Manzano, G. M., Pompéia, S., & Tufik, S. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.01.013 · Cited by 15
Warren, C. V., Kroll, C., & Kopp, B. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105221 · Cited by 12
Clomipramine, a better reference drug for panic/agoraphobia. II. Psychomotor and cognitive effects
Marcourakis, T., Gorenstein, C., & Gentil, V. (1993) · Journal of Psychopharmacology · doi:10.1177/026988119300700403 · Cited by 11
Allen, D., & LADER, M. H. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf00314858 · Cited by 10
“Reaction speed was recorded simultaneously with AVP [Allen et al., 1991], 32 reaction times were recorded and the mean reciprocal calculated.”
MethodSelf-citationAntidepressant Drugs, Cognitive Function and Human Performance
Curran, H. V. (1992) · Elsevier eBooks · doi:10.1016/b978-0-12-650352-4.50018-5 · Cited by 10
Self-citationTime course of chronic diazepam effects on the auditory evoked potential of the rat
Jongsma, M. L. A., van Rijn, C. M., de Bruin, E. A., Dirksen, R., & Coenen, A. M. L. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01481-7 · Cited by 12
Categorising the Behavioural Toxicities of Antidepressants Proposals and Requirements
O’Hanlon, J. F., & Freeman, H. L. (1995) · The British Journal of Psychiatry · doi:10.1192/bjp.166.4.421 · Cited by 9
Effects of Alprazolam on Complex Human Functioning1
Streufert, S., Satish, U., Pogash, R. M., Gingrich, D. L., Landis, J. R., Lonardi, L., Miller, J., Severs, W. B., & Roache, J. D. (1996) · Journal of Applied Social Psychology · doi:10.1111/j.1559-1816.1996.tb00105.x · Cited by 6
Aitken, B., Hayley, A. C., Ford, T. C., Geier, L., Shiferaw, B. A., & Downey, L. A. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231200878 · Cited by 5
“Furthermore, Allen et al. (1991) observed impaired word recall with doses ranging from 0.25 to 0.75 mg at 3 h post-dosing, with effects persisting for up to 10 days of cumulative treatment.”
BackgroundInfluentialEffects of lofepramine and dothiepin on memory and psychomotor function in healthy volunteerso
Allen, D., Curran, H. V., & LADER, M. H. (1993) · Journal of Psychopharmacology · doi:10.1177/0269881193007001061 · Cited by 5
Self-citationRoszkowski, S. C., Babalonis, S. L., Coe, M. A., Nuzzo, P. A., Lofwall, M. R., Fanucchi, L. C., & WALSH, S. L. (2024) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000746 · Cited by 1
Hellriegel, J. (2014) · UCL Discovery (University College London) · Cited by 2
Effects of central nervous system depressant drug overdose on cognitive functions and driving
Dassanayake, W. D. M. T. L. (2012) · Figshare
Executive function deficits in obsessive-compulsive disorder: episode or trait markers
Bannon, S. (2003) · Research Online (University of Wollongong) · Cited by 1
Human psychopharmacology of second generation antidepressants.
Fairweather, D. B. (1996) · University of Surrey Open Research repository
Substance Related Cognitive Dysfunction in Aging
Kanellopoulos, D., & Vallejo, P. S.-B. (2019) · Clinical handbooks in neuropsychology · doi:10.1007/978-3-319-93497-6_19
Metadata
- Authors
- Allen, D., Curran, H. V., & Lader, M.
- ORCID
- Curran, H. V.
- Venue
- European Journal of Clinical Pharmacology
- Published
- 1991-04
- Volume
- 40
- Issue
- 4
- Pages
- 355-362
- ISSN
- 0031-6970 (ISSN-L)
- 1432-1041
- OpenAlex
- W2073266088
- Cited by
- 51
- References
- 33
- Citations by year
- 2023: 2 · 2021: 3 · 2019: 2 · 2016: 1 · 2015: 1 · 2014: 1 · 2012: 2
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Clinical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- clomipramine, alprazolam, repeated dosing, psychomotor performance, cognitive impairment, reaction time, word recall, forgetting, tolerance (pharmacology and immunology), somatic symptoms, benzodiazepines, tricyclic antidepressants, EEG, evoked potentials
- MeSH terms
- Adult, Affect, Alprazolam, Clomipramine, Cognition, Double-Blind Method, Electroencephalography, Evoked Potentials, Auditory, Female, Humans, Male, Memory, Middle Aged, Psychomotor Performance, Salivation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.